BYAH
Park Ha Biological Technology Co., Ltd.
Price Chart
Latest Quote
$0.08
Current Price| Previous Close | $0.09 |
| Open | $0.08 |
| Day High | $0.09 |
| Day Low | $0.07 |
| Volume | 1,292,488 |
Stock Information
| Shares Outstanding | 36.70M |
| Total Debt | $91K |
| Cash Equivalents | $1.35M |
| Revenue | $2.77M |
| Net Income | $-19.41M |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $4.35M |
| EPS (TTM) | $-0.72 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 30/42| Debt to Equity | 0.05 |
| Debt to Earnings | 0.03 |
| Current Ratio | 1.87 |
| Quick Ratio | 1.09 |
| Avg Revenue Growth | 38.96% |
| Profit Margin | 20.09% |
| Return on Equity | 31.78% |
| Avg FCF Growth | -67.82% |
| FCF Yield | 20.09% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.08 | 1,292,488 |
| 2026-01-30 | $0.09 | 3,397,300 |
| 2026-01-29 | $0.10 | 7,230,500 |
| 2026-01-28 | $0.12 | 88,658,400 |
| 2026-01-27 | $0.11 | 1,793,300 |
| 2026-01-26 | $0.15 | 449,500 |
| 2026-01-23 | $0.16 | 220,500 |
| 2026-01-22 | $0.16 | 326,700 |
| 2026-01-21 | $0.16 | 56,700 |
| 2026-01-20 | $0.16 | 128,200 |
| 2026-01-16 | $0.16 | 140,300 |
| 2026-01-15 | $0.16 | 77,200 |
| 2026-01-14 | $0.16 | 173,400 |
| 2026-01-13 | $0.15 | 239,200 |
| 2026-01-12 | $0.16 | 100,000 |
| 2026-01-09 | $0.17 | 65,200 |
| 2026-01-08 | $0.17 | 148,600 |
| 2026-01-07 | $0.17 | 117,800 |
| 2026-01-06 | $0.17 | 175,700 |
| 2026-01-05 | $0.17 | 160,100 |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Income Statement (Annual)
Revenue
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $195,336 | $310,989 | $509,162 | $311,162 |
| Cost Of Revenue | $195,336 | $310,989 | $509,162 | $311,162 |
| Total Revenue | $2,381,851 | $2,459,102 | $1,919,389 | $931,036 |
| Operating Revenue | $2,381,851 | $2,459,102 | $1,919,389 | $876,752 |
Expenses
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Total Expenses | $1,588,137 | $1,278,548 | $1,722,365 | $1,432,012 |
| Other Income Expense | $-1,076 | $-575 | $-7,083 | $17,045 |
| Other Non Operating Income Expenses | $-1,076 | $-575 | $-7,083 | $17,045 |
| Net Non Operating Interest Income Expense | $783 | $1,590 | $69 | $-1,027 |
| Operating Expense | $1,392,801 | $967,559 | $1,213,203 | $1,120,850 |
| Selling And Marketing Expense | $361,327 | $299,615 | $438,603 | $369,034 |
| General And Administrative Expense | $814,857 | $484,955 | $707,487 | $751,816 |
| Interest Expense | - | $0 | $194 | $1,194 |
| Interest Expense Non Operating | - | $0 | $194 | $1,194 |
Income & Earnings
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $478,561 | $852,042 | $191,298 | $-484,958 |
| Net Interest Income | $783 | $1,590 | $69 | $-1,027 |
| Interest Income | $783 | $1,590 | $263 | $167 |
| Normalized Income | $478,561 | $852,042 | $191,298 | $-484,958 |
| Net Income From Continuing And Discontinued Operation | $478,561 | $852,042 | $191,298 | $-484,958 |
| Total Operating Income As Reported | $793,714 | $1,180,554 | $197,024 | $-500,976 |
| Net Income Common Stockholders | $478,561 | $852,042 | $191,298 | $-484,958 |
| Net Income | $478,561 | $852,042 | $191,298 | $-484,958 |
| Net Income Including Noncontrolling Interests | $478,561 | $852,042 | $191,298 | $-484,958 |
| Net Income Continuous Operations | $478,561 | $852,042 | $191,298 | $-484,958 |
| Pretax Income | $793,421 | $1,181,569 | $190,010 | $-484,958 |
| Interest Income Non Operating | $783 | $1,590 | $263 | $167 |
| Operating Income | $793,714 | $1,180,554 | $197,024 | $-500,976 |
| Gross Profit | $2,186,515 | $2,148,113 | $1,410,227 | $619,874 |
Per Share Metrics
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Diluted EPS | $0.02 | $0.03 | $0.01 | $-0.02 |
| Basic EPS | $0.02 | $0.03 | $0.01 | $-0.02 |
Other
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $816,400 | $1,200,617 | $220,695 | $-444,758 |
| Reconciled Depreciation | $22,686 | $20,063 | $30,491 | $39,006 |
| EBITDA (Bullshit earnings) | $816,400 | $1,200,617 | $220,695 | $-444,758 |
| EBIT | $793,714 | $1,180,554 | $190,204 | $-483,764 |
| Diluted Average Shares | $26,200,000 | $26,200,000 | $26,200,000 | $26,200,000 |
| Basic Average Shares | $26,200,000 | $26,200,000 | $26,200,000 | $26,200,000 |
| Diluted NI Availto Com Stockholders | $478,561 | $852,042 | $191,298 | $-484,958 |
| Tax Provision | $314,860 | $329,527 | $-1,288 | $0 |
| Provision For Doubtful Accounts | $179,903 | $152,108 | $6,442 | - |
| Research And Development | $36,714 | $30,881 | $60,671 | - |
| Selling General And Administration | $1,176,184 | $784,570 | $1,146,090 | $1,120,850 |
| Other Gand A | $814,857 | $484,955 | $707,487 | $751,816 |
Balance Sheet (Annual)
Assets
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Net Tangible Assets | $1,498,464 | $1,004,069 | $140,928 | $-578,185 |
| Total Assets | $3,083,283 | $2,264,867 | $2,518,722 | $594,216 |
| Total Non Current Assets | $239,037 | $88,721 | $254,091 | $120,623 |
| Non Current Prepaid Assets | $407 | $9,882 | $3,849 | $13,864 |
| Non Current Deferred Assets | $56,310 | $0 | - | - |
| Non Current Deferred Taxes Assets | $56,310 | $0 | - | - |
| Goodwill And Other Intangible Assets | $7,621 | $8,404 | $9,349 | $0 |
| Other Intangible Assets | $7,621 | $8,404 | $9,349 | - |
| Current Assets | $2,844,246 | $2,176,146 | $2,264,631 | $473,593 |
| Current Deferred Assets | $1,088,400 | $233,476 | $59,520 | $0 |
| Current Deferred Taxes Assets | $0 | $33,830 | $1,167 | $0 |
| Prepaid Assets | $27,198 | $102,388 | $10,574 | $4,688 |
| Inventory | $71,486 | $95,870 | $94,170 | $316,512 |
| Receivables | $1,109,664 | $710,778 | $1,525,656 | $79,707 |
| Other Receivables | $18,441 | $31,487 | $15,837 | $27,714 |
| Loans Receivable | $745,992 | $300,315 | $1,377,676 | $0 |
| Accounts Receivable | $330,892 | $361,735 | $119,212 | $51,993 |
| Allowance For Doubtful Accounts Receivable | $-231,851 | $-90,504 | $-5,833 | $0 |
| Gross Accounts Receivable | $562,743 | $452,239 | $125,045 | $51,993 |
| Cash Cash Equivalents And Short Term Investments | $547,498 | $1,033,634 | $574,711 | $72,686 |
| Cash And Cash Equivalents | $547,498 | $1,033,634 | $574,711 | $72,686 |
| Cash Financial | $547,498 | $1,033,634 | $574,711 | $72,686 |
| Non Current Accounts Receivable | - | - | $178,074 | - |
Debt
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Total Debt | $70,318 | $31,462 | $26,194 | $35,203 |
| Long Term Debt And Capital Lease Obligation | $52,745 | $9,492 | $0 | $15,859 |
| Current Debt And Capital Lease Obligation | $17,573 | $21,970 | $26,194 | $19,344 |
Liabilities
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $1,577,198 | $1,252,394 | $2,368,445 | $1,172,401 |
| Total Non Current Liabilities Net Minority Interest | $52,745 | $9,492 | $0 | $15,859 |
| Current Liabilities | $1,524,453 | $1,242,902 | $2,368,445 | $1,156,542 |
| Current Deferred Liabilities | $325,924 | $250,549 | $1,206,109 | $164,813 |
| Payables And Accrued Expenses | $1,180,956 | $970,383 | $1,136,142 | $972,385 |
| Payables | $1,025,093 | $845,227 | $1,045,295 | $909,393 |
| Total Tax Payable | $1,001,024 | $579,911 | $156,271 | $93,525 |
| Income Tax Payable | $699,633 | $351,691 | $0 | - |
| Accounts Payable | $24,069 | $197,155 | $129,723 | $89,341 |
Equity
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Common Stock Equity | $1,506,085 | $1,012,473 | $150,277 | $-578,185 |
| Total Equity Gross Minority Interest | $1,506,085 | $1,012,473 | $150,277 | $-578,185 |
| Stockholders Equity | $1,506,085 | $1,012,473 | $150,277 | $-578,185 |
| Gains Losses Not Affecting Retained Earnings | $72,586 | $-43,505 | $-45,816 | $-48,830 |
| Other Equity Adjustments | $72,586 | $-43,505 | $-45,816 | $-48,830 |
| Retained Earnings | $271,788 | $-105,233 | $-926,853 | $-1,118,151 |
| Other Equity Interest | - | $-500 | $-500 | $-500 |
Other
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $26,200,000 | $26,200,000 | $26,200,000 | $26,200,000 |
| Share Issued | $26,200,000 | $26,200,000 | $26,200,000 | $26,200,000 |
| Tangible Book Value | $1,498,464 | $1,004,069 | $140,928 | $-578,185 |
| Invested Capital | $1,506,085 | $1,012,473 | $150,277 | $-578,185 |
| Working Capital | $1,319,793 | $933,244 | $-103,814 | $-682,949 |
| Capital Lease Obligations | $70,318 | $31,462 | $26,194 | $35,203 |
| Total Capitalization | $1,506,085 | $1,012,473 | $150,277 | $-578,185 |
| Additional Paid In Capital | $1,161,211 | $1,161,211 | $1,122,946 | $588,796 |
| Capital Stock | $500 | $500 | $500 | $500 |
| Common Stock | $500 | $500 | $500 | $500 |
| Long Term Capital Lease Obligation | $52,745 | $9,492 | $0 | $15,859 |
| Current Deferred Revenue | $325,924 | $250,549 | $1,206,109 | $164,813 |
| Current Capital Lease Obligation | $17,573 | $21,970 | $26,194 | $19,344 |
| Current Accrued Expenses | $155,863 | $125,156 | $90,847 | $62,992 |
| Dueto Related Parties Current | $0 | $68,161 | $759,301 | $726,527 |
| Net PPE | $174,699 | $70,435 | $62,819 | $106,759 |
| Accumulated Depreciation | $-167,372 | $-142,053 | $-123,383 | $-109,576 |
| Gross PPE | $342,071 | $212,488 | $186,202 | $216,335 |
| Leases | $106,775 | $21,953 | $0 | - |
| Other Properties | $70,739 | $31,864 | $27,795 | $36,896 |
| Machinery Furniture Equipment | $164,557 | $158,671 | $158,407 | $179,439 |
| Properties | $0 | $0 | $0 | - |
| Finished Goods | $48,880 | $59,130 | $53,995 | $127,346 |
| Raw Materials | $22,606 | $36,740 | $40,175 | $189,166 |
| Duefrom Related Parties Current | $14,339 | $17,241 | $12,931 | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Free Cash Flow | $874,901 | $103,861 | $1,430,416 | $-510,765 |
Operating Activities
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Operating Cash Flow | $960,470 | $126,537 | $1,442,306 | $-497,858 |
| Cash Flow From Continuing Operating Activities | $960,470 | $126,537 | $1,442,306 | $-497,858 |
Investing Activities
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Capital Expenditure | $-85,569 | $-22,676 | $-11,890 | $-12,907 |
| Investing Cash Flow | $-508,143 | $1,023,419 | $-1,547,610 | $-12,907 |
| Cash Flow From Continuing Investing Activities | $-508,143 | $1,023,419 | $-1,547,610 | $-12,907 |
| Net Other Investing Changes | $-422,574 | $1,046,095 | $-1,535,720 | - |
Financing Activities
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $500 | $38,265 | $534,149 | $263,068 |
| Financing Cash Flow | $-957,389 | $-676,925 | $669,652 | $498,627 |
| Cash Flow From Continuing Financing Activities | $-957,389 | $-676,925 | $669,652 | $498,627 |
| Net Other Financing Charges | $-888,754 | - | - | - |
| Net Common Stock Issuance | $500 | $38,265 | $534,149 | $263,068 |
| Common Stock Issuance | $500 | $38,265 | $534,149 | $263,068 |
Other
| Metric | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-73,310 | $-776,083 | $-257,557 | $-395,526 |
| Issuance Of Debt | $4,175 | $60,893 | $393,060 | $631,085 |
| Interest Paid Supplemental Data | $0 | $0 | $194 | $1,194 |
| End Cash Position | $547,498 | $1,033,634 | $574,711 | $72,686 |
| Beginning Cash Position | $1,033,634 | $574,711 | $72,686 | $81,128 |
| Effect Of Exchange Rate Changes | $18,926 | $-14,108 | $-62,323 | $3,696 |
| Changes In Cash | $-505,062 | $473,031 | $564,348 | $-12,138 |
| Net Issuance Payments Of Debt | $-69,135 | $-715,190 | $135,503 | $235,559 |
| Net Long Term Debt Issuance | $-69,135 | $-715,190 | $135,503 | $235,559 |
| Long Term Debt Payments | $-73,310 | $-776,083 | $-257,557 | $-395,526 |
| Long Term Debt Issuance | $4,175 | $60,893 | $393,060 | $631,085 |
| Net PPE Purchase And Sale | $-85,569 | $-22,676 | $-11,890 | $-12,907 |
| Purchase Of PPE | $-85,569 | $-22,676 | $-11,890 | $-12,907 |
| Change In Working Capital | $254,405 | $-911,066 | $1,173,763 | $-53,569 |
| Change In Other Working Capital | $68,725 | $-989,082 | $1,172,485 | $-118,075 |
| Change In Other Current Liabilities | $-30,435 | $-44,654 | $-33,032 | $-3,349 |
| Change In Other Current Assets | $9,620 | $178,016 | $-187,491 | $-8,619 |
| Change In Payables And Accrued Expense | $254,716 | $542,018 | $178,257 | $146,530 |
| Change In Accrued Expense | $27,450 | $35,281 | $39,370 | $86,993 |
| Change In Payable | $227,266 | $506,737 | $138,887 | $59,537 |
| Change In Account Payable | $-176,130 | $69,427 | $56,808 | $44,827 |
| Change In Tax Payable | $403,396 | $437,310 | $82,079 | $14,710 |
| Change In Income Tax Payable | $403,396 | $437,310 | $82,079 | $14,710 |
| Change In Prepaid Assets | $76,909 | $8,959 | $-6,190 | $-4,149 |
| Change In Inventory | $10,472 | $-2,823 | $193,581 | $-19,232 |
| Change In Receivables | $-135,602 | $-603,500 | $-143,847 | $-46,675 |
| Changes In Account Receivables | $-98,740 | $-337,745 | $-87,783 | $-18,560 |
| Other Non Cash Items | $30,425 | $45,896 | $32,902 | $1,663 |
| Provisionand Write Offof Assets | $179,903 | $152,108 | $6,442 | $0 |
| Asset Impairment Charge | $15,955 | $1,231 | $8,698 | $0 |
| Deferred Tax | $-21,465 | $-33,737 | $-1,288 | $0 |
| Deferred Income Tax | $-21,465 | $-33,737 | $-1,288 | $0 |
| Depreciation Amortization Depletion | $22,686 | $20,063 | $30,491 | $39,006 |
| Depreciation And Amortization | $22,686 | $20,063 | $30,491 | $39,006 |
| Net Income From Continuing Operations | $478,561 | $852,042 | $191,298 | $-484,958 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |